JPMorgan subsidiary discloses dealings in Kangji Medical shares

J.P. Morgan Securities PLC, an associate of the Offeror, disclosed its dealings in Kangji Medical Holdings Limited shares on October 7, 2025. The firm purchased 500 units of "other types of securities" (e.g., equity swaps) on October 6, 2025.

The total amount paid for these securities was $4,437.60. Both the highest and lowest prices paid per unit were recorded at $8.88. These dealings were executed for J.P. Morgan Securities PLC's own account as part of hedging Delta 1 products resulting from wholly unsolicited client-driven orders.

J.P. Morgan Securities PLC is classified as a Class (5) associate connected with the Offeror in the ongoing privatization by way of scheme of arrangement. The entity is ultimately owned by JPMorgan Chase & Co. This disclosure was made pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers.